Skip to search.
 NZX 50 Down 0.40%

Keryx Biopharmaceuticals, Inc. (KERX)

-NasdaqCM
5.67 Up 0.15(2.72%) 3 Dec 10:00
Prev Close:5.52
Open:5.56
Bid:4.00 x 200
Ask:5.79 x 2000
1y Target Est:6.86
Beta:3.1443
Earnings Date:23 Feb - 27 Feb (Est.)
Day's Range:5.50 - 5.78
52wk Range:2.80 - 7.80
Volume:1,083,949
Avg Vol (3m):1,580,670
Market Cap:600.79m
P/E (ttm):N/A
EPS (ttm):-1.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 2.72%600.79m
BAXUp 0.87%23.94b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.42
Quarterly EPS Est (Dec-16) :-0.21
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback